PSS eBulletin
| Issue No 62 31 Aug 2010 |
|
| News articles for this edition |
 | Selamat Hari Raya
On behalf of the Council and Secretariat of PSS, we like to wish all our Muslim members and colleagues a peaceful Ramadan and Selamat Hari Raya.
read more>> |
| |
|
|
 | Class Reunion....Years Later
One of the most memorable aspects of becoming a pharmacist is the process of becoming one, ie. the not-so-sophisticated days in the university. That's exactly why reliving those days is so refreshing!
read more>> |
| |
|
|
 | NDM-1: Potential Health Threat?
In recent months, the buzz word lingering in the healthcare circle has been NDM-1 or the New Delhi metallo-beta-lactamase. NDM-1, a new gene in bacteria, has been dubbed as a new threat that can cause a breakdown in our fight against multi-drug resistant bug.
read more>> |
| |
|
|
 | PSS Noticeboard
Check out the following which we have lined up for your benefits. Do take note and mark them on your calendar. If you have other thoughts or idea to be included, please feel free to provide your feedback to n n webmaster@pss.org.sg This email address is being protected from spam bots, you need Javascript enabled to view it
read more>> |
| |
|
|
 | Pharma & Healthcare News
Here are some brief pharma news for your quick update:
• Tiger Balm Received US FDA Warning
• FDA Approved New Morning-After Pill
• HSA Website to Announce New Drug Approvals
• Teva Pharma to Acquire Ratiopharm
read more>> |
| |
|
|
 | Patient & Drug Safety News
Here are some safety advisory and news for your speed update.
• Recall of Panvax® Junior H1N1 Vaccine in Singapore
• Recall of 1 Day Acuvue® TruEye™ Brand Contact Lenses
• Bupivacaine (Marcain®) & reports of lack of efficacy
• Zoledronic acid (Aclasta®) & reports of renal impairment
• Orlistat and reports of severe liver injury
• Haemolysis associated with WinRho® SDF injection
read more>> |
| |
|
|
 | Advertisements
The following jobs/events are currently available. Kindly apply/register directly based on the information provided. Best of luck!
read more>> |
| |
|
|
|
|
|
|